- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
Setting: Emergency department
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Molnupiravir
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Syndromic diagnostic testing
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Community
- Primary care
- Non-hospital health centre
- Emergency department
- SARS-CoV-2
- Post-COVID-19
- Acute COVID-19
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Adults (18-64 years)
- Hospital
- Primary care
- Non-hospital health centre
- Emergency department
- Long-term care facility
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Nasopharyngeal swab
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Blood sample
- Nasopharyngeal swab
- Urine sample
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Emergency department
- SARS-CoV-2
- Post-COVID-19